Martin I. Freed - Dec 13, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director
Signature: /s/ by David Tyronne Howton as attorney-in-fact for Martin I. Freed
Stock symbol: SLDB
Transactions as of: Dec 13, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/15/2022, 05:14 PM
Previous filing: Jun 9, 2022
Next filing: Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SLDB	Director Stock Option (Right to Buy)	Award	$0	+9.65K		$0.00	9.65K	Dec 13, 2022	Common Stock	9.65K	$6.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Remarks:

Exhibit Index: 24.1 Power of Attorney